Overview
Zulvikar Ulhaq practices in Cibinong, Indonesia. Ulhaq is rated as an Elite expert by MediFind in the treatment of Acrofacial Dysostosis Nager Type. Their top areas of expertise are Acrofacial Dysostosis Nager Type, Acrofacial Dysostosis Catania Type, Acrofrontofacionasal Dysostosis Syndrome, and Treacher Collins Syndrome.
Their clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Acrofacial Dysostosis Nager Type.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acrofacial Dysostosis Nager Type
- Distinguished
- Acrofacial Dysostosis Catania Type
- Acrofacial Dysostosis Rodriguez Type
- Acrofrontofacionasal Dysostosis Syndrome
- Crouzon SyndromeUlhaq isDistinguished. Learn about Crouzon Syndrome.
- Treacher Collins SyndromeUlhaq isDistinguished. Learn about Treacher Collins Syndrome.
- Advanced
- Retinitis PigmentosaUlhaq isAdvanced. Learn about Retinitis Pigmentosa.
- Retinopathy Pigmentary Mental Retardation
- Experienced
- Abdominal Obesity Metabolic Syndrome
- Achalasia Microcephaly Syndrome
- Carnitine Palmitoyltransferase 1 Deficiency
- CataractUlhaq isExperienced. Learn about Cataract.
- Cortical DysplasiaUlhaq isExperienced. Learn about Cortical Dysplasia.
- COVID-19Ulhaq isExperienced. Learn about COVID-19.